Skip to content

Safety Profile Following Pentabio Vaccination in Indonesian Infants

Phase IV, Study of Safety Profile Following Pentabio Vaccination in Indonesian Infants

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02093286
Enrollment
4000
Registered
2014-03-20
Start date
2014-05-31
Completion date
2014-12-31
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Pentabio Vaccine, Safety, Infants, Booster Dose, DTwP/HepB/Hib

Brief summary

To assess any serious systemic reaction within 30 minutes after Pentabio immunization

Detailed description

Any local and systemic reaction after Pentabio immunization

Interventions

None listed

Sponsors

PT Bio Farma
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
2 Months to 11 Months
Healthy volunteers
Yes

Inclusion criteria

* Immunization with Pentabio vaccine * Parents already understood the consequences to be involved in this study and having signed the informed consent form * Parents agree and willing to fill in the Diary Card, to record all the reactions after immunization

Exclusion criteria

* Given simultaneously with other vaccines or with the interval less than 1 month with other vaccination except OPV/IPV.

Design outcomes

Primary

MeasureTime frameDescription
Any serious adverse event occurring from inclusion until 30 minutes after the injection30 minuteslocal and systemic reaction

Secondary

MeasureTime frameDescription
Percentage of local and systemic events occurring within 72 hours after each injection72 hoursany local and systemics events
Percentage of local and systemic events occurring from 72 hours up to 28 days following injection.25 daysany local and systemic events
Percentage of serious adverse events within 28 days after injection28 daysAny serious adverse events

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026